VAX014
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VAX014, covering 2025-11-25 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors [Phase 1]